Now Up, After a Down

Biotech stocks have made a comeback, writes Saumya Vaishampayan at the Wall Street Journal. The Nasdaq Biotechnology Index hit its low of the year in September but it has clawed its way back and has risen some 18 percent since then, bringing it now up 13 percent for 2015.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.